Related Articles
Celecoxib upregulates ULBP‑1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity
Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma
Interferon-α resistance can be reversed by inhibition of IFN-α-induced COX-2 expression potentially via STAT1 activation in A549 cells
Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors
Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib